Advertisement
Organisation › Details
Pamplona Capital Management LLP
Pamplona Capital Management is a London, New York, and Boston-based specialist investment manager established in 2005 that provides an alternative investment platform across private equity, fund of hedge funds, and single-manager hedge fund investments. Pamplona manages over $10 billion in assets across a number of funds for a variety of clients including public pension funds, international wealth managers, multinational corporations, family offices, and funds of hedge funds. Pamplona invests long-term capital across the capital structure of its portfolio companies in both public and private market situations and has been one of the most active private equity investors in healthcare in recent years. Notable recent Pamplona healthcare investments include nThrive, Formativ Health, Brighton Health Group, Alvogen, Spreemo, PatientCo and Intralign. Please see www.pamplonafunds.com for further information. *
Start | 2005-01-01 established | |
Group | Pamplona Capital (Group) | |
Industry | private equity | |
Industry 2 | LIFE SCIENCES | |
Region | London, Greater London | |
Country | United Kingdom (GB) | |
City | n. a. London | |
Address record changed: 2020-12-02 | ||
Basic data | Employees | n. a. |
Currency | USD | |
Annual sales | 10,000,000,000 (assets, managed (2017) 2017-06-20) | |
* Document for »About Section«: Parexel International Corporation. (6/20/17). "Press Release: Parexel International Enters Definitive Agreement to Be Acquired by Pamplona Capital Management for $88.10 Per Share in Cash". Boston, MA & New York, NY. | ||
Record changed: 2017-06-27 |
Advertisement
More documents for Pamplona Capital (Group)
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top